Downregulating sCLU enhances the sensitivity of hepatocellular carcinoma cells to gemcitabine by activating the intrinsic apoptosis pathway.
about
Clusterin: Review of research progress and looking ahead to direction in hepatocellular carcinomaHeat shock proteins in hepatocellular carcinoma: Molecular mechanism and therapeutic potential.Secretory Clusterin Mediates Oxaliplatin Resistance via the Gadd45a/PI3K/Akt Signaling Pathway in Hepatocellular Carcinoma.Therapeutic role of meloxicam targeting secretory clusterin-mediated invasion in hepatocellular carcinoma cells.Role of secretory clusterin in hepatocarcinogenesis
P2860
Downregulating sCLU enhances the sensitivity of hepatocellular carcinoma cells to gemcitabine by activating the intrinsic apoptosis pathway.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Downregulating sCLU enhances t ...... e intrinsic apoptosis pathway.
@en
Downregulating sCLU enhances t ...... e intrinsic apoptosis pathway.
@nl
type
label
Downregulating sCLU enhances t ...... e intrinsic apoptosis pathway.
@en
Downregulating sCLU enhances t ...... e intrinsic apoptosis pathway.
@nl
prefLabel
Downregulating sCLU enhances t ...... e intrinsic apoptosis pathway.
@en
Downregulating sCLU enhances t ...... e intrinsic apoptosis pathway.
@nl
P2093
P2860
P1476
Downregulating sCLU enhances t ...... he intrinsic apoptosis pathway
@en
P2093
P2860
P2888
P304
P356
10.1007/S10620-014-3111-9
P577
2014-03-27T00:00:00Z